Archimedes Pharma UK Overview
- Founded
-
1996

- Status
-
Acquired/Merged
- Employees
-
23

- Latest Deal Type
-
Buyout/LBO
- Financing Rounds
-
1
Archimedes Pharma UK General Information
Description
Provider of pharmaceutical products. The company offers Gliadel, a treatment for high-grade gliomas; Zomorph for cancer pain; Nozinan, an anti-emetic for nausea and vomiting in advanced cancer patients; and Pabrinex, a high-potency formulation of vitamins B and C for chronic alcoholics. It operates in the United Kingdom, France, and Germany.
Contact Information
Website
www.archimedespharma.com
Formerly Known As
Link Holdings
Ownership Status
Acquired/Merged
Financing Status
Formerly PE-Backed
Primary Office
- 250 South Oak Way
- Green Park
- Reading RG2 6UG
- England, United Kingdom
+44 0118 000 0000
Archimedes Pharma UK Valuation & Funding
Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
---|
Archimedes Pharma UK Board Members (1)
Name | Representing | Role | Since |
---|---|---|---|
000 000 | Self | Board Member | 000 0000 |